Name: BTAI Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: BTAI, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does BTAI have?

Accepted Answer

BioXcel Therapeutics, Inc. (BTAI) has 12 SEC Form 4 filings (16 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jun 17, 2026.

Question 2

When was the most recent SEC Form 4 filing for BTAI?

Accepted Answer

The most recent Form 4 filing for BTAI on Tracefour is dated Jun 17, 2026.

Question 3

What is the net insider flow at BTAI over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at BTAI have net sold $43K based on SEC Form 4 disclosures.

Question 4

What is the total insider buy and sell value at BTAI in the current window?

Accepted Answer

Inside the rolling window, insiders at BTAI bought $0 and sold $43K based on SEC Form 4 filings.

						Source
Yocca FrankFirst filing	Chief Scientific Officer	Sale	6,845	$7K	May 22	SEC ↗
Rodriguez JavierFirst filing	See Remarks	Sale	6,560	$7K	May 22	SEC ↗
Steinhart Richard IFirst filing	Chief Financial Officer	Sale	6,845	$7K	May 22	SEC ↗
Mehta VimalFirst filing	CEO and President	Sale	19,419	$21K	May 22	SEC ↗

BTAI

Related companies